© 2026 Vannoni
A patient in her mid 40s mentioned, almost in passing, that her periods had stopped at 37. She had been through the hot flashes, the sleep disruption, the fertility conversations. What nobody had told her was that the age her periods stopped is one of the more useful pieces of cardiovascular information in her entire chart.
That gap is closing, and two recent studies are part of the reason.
First, What Are the Definitions?
Menopause is dated one full year after your final menstrual period. In the United States the average age is 51.
● Premature menopause means before age 40.
● Early menopause means between 40 and 44.
● Menopause at 45 or later falls in the typical range.
The distinction matters more than it sounds, because the research keeps finding that the risk is concentrated at the earliest end.
At Madison Avenue Concierge Medicine, Dr. Meyer keeps himself and his patients on the cutting edge of every new medical development and study.
That’s the Madison Avenue Concierge Medicine advantage.
Be in the know regarding your health.
No excuses.
Join Madison Avenue Concierge Medicine
What Did the New Study Find?
Researchers presented an analysis at The Menopause Society’s annual meeting in October 2026 using data from the Atherosclerosis Risk in Communities study, or ARIC. ARIC is one of the workhorses of American cardiology: about 16,000 adults enrolled in 1985 from four communities, followed for more than three decades.
This analysis looked at 4,710 women, aged 45 to 64 at enrollment, none of whom had cardiovascular disease when they started. They were followed for an average of 21.4 years, during which 1,570 cardiovascular events occurred.
Compared with women whose menopause came at 45 or later, women with premature menopause had:
● 30% higher risk of coronary heart disease (hazard ratio 1.30)
● 19% higher risk of cardiovascular disease overall (hazard ratio 1.19)
● No measurable increase in stroke or heart failure
Here is the part I find most useful clinically: women with early menopause, between 40 and 44, did not show a significant increase in risk in this analysis. The signal was specific to menopause before 40.
Madison Avenue Concierge Medicine relies on a wide range of diagnostic technologies to assess cardiovascular health.
These tools allow Dr. Meyer to make accurate diagnoses and inform evidence-based treatment plans.
What Direction Did the Second Study Point In?
In March 2026, researchers at Northwestern published a larger analysis in JAMA Cardiology. They pooled 10,036 postmenopausal women from six long-running American studies, including the Framingham Heart Study, ARIC, and the Women’s Health Initiative, with follow-up spanning 1964 to 2018 and more than 1,000 coronary events.
Their finding: women who reached natural menopause before 40 had roughly a 40% higher lifetime risk of coronary heart disease. The association held after accounting for smoking, obesity, high blood pressure, and diabetes, at 41% for Black women and 39% for white women.
That study also surfaced something that deserves attention. Premature menopause was about three times more common among Black women than white women in these cohorts, 15.5% versus 4.8%. The lead author attributed that gap to a combination of life-course exposures, health conditions, and structural inequities rather than to inherent biology.
Two different research teams, different methods, same direction. That is the kind of agreement that should change a conversation in the exam room.
Why Would Losing Estrogen Early Matter?
Estrogen does quiet work on the cardiovascular system, and the menopause transition makes its absence visible. The American Heart Association’s scientific statement on menopause and cardiovascular risk documented several changes that track with the transition itself rather than with simple aging:
● Cholesterol shifts. Total cholesterol, LDL, and apolipoprotein B rise sharply right around the final menstrual period.
● Fat moves. Visceral fat, the metabolically active kind around the organs, increases. In one large cohort, fat gain roughly doubled in the two years before the final period.
● Muscle declines. Loss of lean mass is independently associated with the transition, and muscle is where much of your glucose gets used.
● Arteries stiffen. Measurable arterial stiffening appears within about a year of the final menstrual period, and traditional risk factors do not explain it.
Now consider that a woman whose menopause arrives at 37 lives with those changes for an extra 14 years compared with a woman whose menopause arrives at 51. As the Northwestern lead author put it, when menopause happens before 40, women still have more than half their life expectancy ahead of them.
Our Concierge Medicine Services
At Madison Avenue Cardiovascular & Concierge Medicine, Dr. Mark Meyer offers the most exclusive medical care through premier membership to our concierge medicine services.
What Are These Studies Not Saying?
I want to be careful here, because headlines on this topic tend to outrun the data.
These are observational studies. They show association, not causation. It remains genuinely unclear whether the early loss of ovarian hormones drives vascular disease, or whether some women carry an underlying risk profile that produces both early menopause and heart disease. Both could be true at once.
Age at menopause was self-reported. In the ARIC analysis, women recalled when their periods stopped, sometimes decades later. Recall is imperfect.
A 30% relative increase is not a verdict. It raises your risk relative to another group. It does not tell you what will happen to you, and it says nothing about what happens once you start managing the modifiable pieces.
This is not a reason for alarm at 40. It is a reason for information. The vast majority of coronary heart disease is preventable, and the advantage of knowing early is that you have decades to act.
Join Our Concierge Membership Program
What Do I Do with This Information?
One concrete step: make sure your age at menopause is written in your chart and that your physician has actually looked at it. Premature menopause has been recognized as a risk-enhancing factor in cholesterol guidelines since 2018, meaning it can tip a borderline decision about starting a statin. The 2026 dyslipidemia guideline continues to list early menopause among the reproductive factors that should inform risk decisions. Despite that, it often goes unrecorded.
If you went through menopause before 40, whether naturally, surgically, or after cancer treatment, bring it up specifically at your next visit. Ask how it changes your risk assessment and what your physician wants to monitor. In a concierge practice, where visits are long enough to take a full reproductive history, there is no good reason for this to be missed.
Menopause before 40 is associated with meaningfully higher coronary heart disease risk, and two independent 2026 studies now point the same way. The association is real, it is not destiny, and the practical response is earlier attention rather than worry. Knowing the number gives you a long runway.
Sources
1. Heart Risk From Premature Menopause Linked to Higher Blood Sugar. U.S. News & World Report / HealthDay. October 2026. https://www.usnews.com/news/health-news/articles/2026-10-22/heart-risk-from-premature-menopause-linked-to-higher-blood-sugar
2. Xing Z, et al. Premature Menopause and Cardiovascular Disease Risk in the ARIC Study: Mediation by Insulin Resistance. Presented at The Menopause Society Annual Meeting, San Diego, October 2026 (Abstract P-48). Reported by Patient Care Online. https://www.patientcareonline.com/view/insulin-resistance-may-partly-explain-higher-cardiovascular-risk-after-premature-menopause
3. Premature Menopause Is Connected to CVD: Could Insulin Resistance Offer a Solution? Healio. October 2026. https://www.healio.com/news/womens-health-ob-gyn/20261020/premature-menopause-is-connected-to-cvd-could-insulin-resistance-offer-a-solution
4. Premature Menopause Raises Long-Term Heart Risk by 40%. Northwestern Now. March 2026. https://news.northwestern.edu/stories/2026/03/premature-menopause-raises-long-term-heart-risk-by-40
5. National Heart, Lung, and Blood Institute. Atherosclerosis Risk in Communities (ARIC) Study. https://www.nhlbi.nih.gov/science/atherosclerosis-risk-communities-aric-study
6. El Khoudary SR, et al. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention. A Scientific Statement From the American Heart Association. Circulation. 2020. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000912
7. Atherosclerotic Cardiovascular Disease Risk Assessment and Menopause: Current Evidence. American College of Cardiology. https://www.acc.org/Latest-in-Cardiology/Articles/2022/04/18/12/39/Atherosclerotic-Cardiovascular-Disease-Risk-Assessment-and-Menopause
8. Understanding the 2026 Dyslipidemia Guidelines: CAC Scoring, Risk Enhancers, and Incidental CAC. HCPLive. https://www.hcplive.com/view/understanding-the-2026-dyslipidemia-guidelines-2026-guidelines-cac-scoring-risk-enhancers-incidental-cac
9. Premature Menopause Linked to Higher Heart Disease Risk and Insulin Levels. News-Medical. October 2026. https://www.news-medical.net/news/20261020/Premature-menopause-linked-to-higher-heart-disease-risk-and-insulin-levels.aspx
